Biomarkers for monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma

Funding Cycle:

2022-2023

Name:

Florentin Späth

Type of Award:

Career Development Award

Home Institution:

Umeå University, Sweden

Host Institution:

University of Adelaide, Australia

Description

In this collaborative research project, we aim to identify and develop blood biomarkers improving MGUS follow-up. To achieve this, blood-based proteomic analysis using untargeted i3-D/LC mass spectrometry in unique prospective longitudinal blood samples (n=880) collected in participants of the Northern Sweden Health and Disease Study (UmeÃ¥ University, Sweden) is performed. Routine and novel biomarkers will be included in a novel risk score that could help to improve the stratification of MGUS patients.

Why Become a Member

The International Myeloma Society is a professional, scientific, and medical society established to bring together clinical and experimental scientists involved in the study of myeloma. The purpose of this society is to promote research, education, clinical studies (including diagnosis and treatment), workshops, conferences, and symposia on all aspects of multiple myeloma worldwide.

The IMS is a membership organization comprised of basic research scientists, and clinical investigators in the field along with physicians and other healthcare practitioners.

See All of the Member Benefits

Become a Member Today